General Information Eslicarbazepine acetate is an anticonvulsant agent used as an adjunct to treat partial-onset seizures in patients with inadequate clinical response to conventional antiepileptic therapy.
It is a prodrug of eslicarbazepine (licarbazepine) which is a metabolite of oxcarbazepine. Eslicarbazepine acetate was recently approved in Europe for the treatment of adjunctive therapy for partial-onset of seizures, with or without secondary generalizations, in adults with epilepsy.
Regulations Eslicarbazepine acetate has In-house specification, DMF under filing.
Therapeutic Category Neurosurgery
Available Formulations Tablet
Hot Tags: Eslicarbazepine Acetate, China, Suppliers, Manufacturers, Factory
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies.
Privacy Policy